DANZITEN

NILOTINIB · Azurity Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DANZITEN, covering 2024-11-07 to 2026-04-14. Get the full timeline:

Most recent: FDA Approved: DANZITEN — Supplemental Application (Azurity Pharmaceuticals, Inc.)